Pediatric Cancer US FDA Will Take Rational Approach To Requiring Combination Studies

Pediatric Cancer: US FDA Will Take ‘Rational’ Approach To Requiring Combination Studies

13:09 EDT 25 Jun 2019 | SCRIP

Agency urged to prioritize studies based on strength of preclinical and adult data, and good mechanistic understanding of how multiple...